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Innate immune recognition of bacteria is the first requirement for mounting an effective
immune response able to control infection. Over the previous decade, the general para-
digm was that extracellular bacteria were only sensed by cell surface-expressed Toll-like
receptors (TLRs), whereas cytoplasmic sensors, including members of the Nod-like recep-
tor (NLR) family, were specific to pathogens capable of breaching the host cell membrane.
It has become apparent, however, that intracellular innate immune molecules, such as the
NLRs, play key roles in the sensing of not only intracellular, but also extracellular bacterial
pathogens or their components. In this review, we will discuss the various mechanisms
used by bacteria to activate NLR signaling in host cells.These mechanisms include bacterial
secretion systems, pore-forming toxins, and outer membrane vesicles. We will then focus
on the influence of NLR activation on the development of adaptive immune responses in
different cell types.
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INTRODUCTION
A balanced relationship between humans and their microbiota is
required for a variety of biological functions, including optimal
protection against invasion by microbial pathogens, development
of the mucosal immune system, and control of metabolic processes
[reviewed in Ref. (1)]. The ability of the host immune system
to distinguish between commensals and pathogens is required to
avoid the development of persistent immune responses against the
normal microbiota, yet maintain appropriate immune responses
to pathogens. However, bacterial pathogens are able to avoid or
subvert the host immune system to promote their survival and
colonization. To this end, bacteria can either secrete different
components into the extracellular medium or inject molecules
into the host cell cytoplasm. In parallel, host cells have developed
a wide range of pattern-recognition receptors (PRRs), includ-
ing Toll-like receptors (TLRs) and Nod-like receptors (NLRs), to
detect microorganism- and/or danger-associated molecular pat-
terns (MAMPS and DAMPS, respectively) present in the extra-
cellular medium or in their cytoplasm. MAMPS include viru-
lence factors, but also essential components of both commensals
and pathogens, e.g., lipopolysaccharide (LPS), peptidoglycan, or
nucleic acids. Recent studies have shown that the recognition of
the microbiota that takes place in the gut is necessary for the devel-
opment of a normal epithelium, by controlling the balance of
proliferation and differentiation, as well as maintaining a properly
functioning immune system (1, 2).
Over the previous decade, the general paradigm was that extra-
cellular bacteria were only sensed by cell surface-expressed TLRs,
whereas cytoplasmic sensors, including members of the NLR fam-
ily, were specific to pathogens capable of breaching the host cell
membrane. Structurally, NLRs share a typical tripartite architec-
ture with a conserved central nucleotide-binding domain, which
restrains the catalytic activity of NLR family proteins. This central
domain is named NACHT after the original proteins which defined
the features of this domain: neuronal apoptosis inhibitory protein
(NAIP), MHC class II transcription activator (CIITA), incom-
patibility locus protein from Podospora anserine (HET-E), and
a telomerase-associated protein (TP1). At the C-terminal region
of NLR proteins are a series of leucine-rich repeats (LRRs) that
are believed to initiate NLR activation after recognition of the
appropriate signal, although this mechanism is still unclear (3).
The N-terminal effector domain, which specifies the function of
NLRs, is less conserved. Indeed, NLRs may harbor either a pyrin
domain (PYD), a caspase-activation and recruitment domain
(CARD), a baculovirus inhibitor of apoptosis domain (BIR), or
an as yet characterized domain (Table 1) (4). To date, 23 NLR
family members have been reported, each playing different roles
in pathogen recognition, homeostasis, apoptosis, or gut devel-
opment [reviewed in Ref. (4)]. In the context of host-pathogen
responses, NLR activation has been shown to induce the pro-
duction of pro-inflammatory effectors through either nuclear
translocation of Nuclear Factor-κB (NF-κB) or formation of high-
molecular-weight platforms, named inflammasomes, which acti-
vate caspase-1. The main substrates of caspase-1 are cytokine pro-
forms of IL-1β and IL-18, which are usually expressed in an NF-
κB-dependent manner. Hence, to be expressed in a fully mature
form, these cytokines require regulation at both transcriptional
and post-transcriptional levels. Several distinct inflammasomes
have been described in the literature, consisting of different scaf-
folding proteins of the NLR or the PYHIN (PYRIN and HIN-200)
superfamilies [reviewed in Ref. (5)].
Despite their intracellular localization, it has become apparent
that NLRs play key roles in the sensing of not only intracellular, but
also extracellular bacterial pathogens or their components. In this
review, we will summarize the mechanisms used by extracellular
pathogens to deliver bacterial components into host cells and how
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Table 1 | NLR family members and bacterial recognition.
Effector domain NLR family member Bacteria NLRs ligands Activation mechanism Reference
CARD NOD1 H. pylori Peptidoglycan T4SS Viala et al. (6)
H. pylori Peptidoglycan OMVs Kaparakis et al. (7), Bielig et al. (8),
Chatterjee and Chaudhuri (9)P. aeruginosa
N. gonorrhoeae
V. cholerae
S. typhimurium T3SS Keestra et al. (10)
NLRC4/NAIP2a S. typhimurium PrgJ T3SS Kofoed and Vance (11), Zhao et al. (12)
B. pseudomallei BsaK
E. coli EprJ, EscI
S. flexneri MxiI
P. aeruginosa PscI
NLRC4/NAIP5a S. typhimurium Flagellin T3SS Kofoed and Vance (11), Zhao et al. (12)
NLRC4/NAIP C. violaceum CprI Zhao et al. (12)
NLRP12 Y. pestis ? T3SS Vladimer et al. (13)
PYR NLRP3 N. gonorrhoeae Lipooligosaccharide OMVs, LOS Fisseha et al. (14), Duncan et al. (15)
L. monocytogenes Listeriolysin O PFT Gurcel et al. (16), Mariathasan et al.
(17), Harder et al. (18), Munoz-Planillo
et al. (19), Dunne et al. (20), McCoy et
al. (21), McCoy et al. (22), McNeela et
al. (23), Kebaier et al. (24), Holzinger et
al. (25)
S. aureus Hemolysins and PVL
A. hydrophila Aerolysin
A. veronii Aerolysin
B. pertussis CyaA
S. pneumoniae Pneumolysin
S. pyogenes Streptolysin O
V. vulnificus HlyA
V. cholerae MARTX
BYR NLRP1 B. anthracis Anthrax lethal toxin Boyden and Dietrich (26)
NLR family members are classified depending on the function of the N-terminal effector domain: CARD, caspase-activation and recruitment domain; PYD, pyrin
domain; BIR, baculovirus inhibitor domain.
aIndicates that proteins are expressed in mice only. The ligands and the activation mechanisms are detailed in the text.
infections by these microorganisms are sensed via NLRs. Lastly,
we will discuss the importance of the activation of innate immu-
nity receptors, such as NLRs, in tailoring an appropriate adaptive
immune response.
MECHANISMSWHEREBY BACTERIAL COMPONENTS GAIN
ACCESS TO THE CYTOPLASM
BACTERIAL SECRETION SYSTEMS
Bacteria that need to deliver their effectors across both bacter-
ial and cell membranes have developed highly specialized secre-
tion systems to reach their cytoplasmic targets. Among the six
described secretion systems, the injection of bacterial components
through either type-3 or type-4 secretion systems (T3SS and T4SS,
respectively) has been reported to result in the activation of NLR
signaling in host cells (Figure 1).
The T3SS, or “injectisome,” is a specialized molecular machine
which is closely related to the bacterial flagellar apparatus. T3SSs
have been identified in numerous Gram-negative bacteria, includ-
ing pathogens, symbionts, and commensals, suggesting that the
T3SS is not a hallmark of pathogenic microorganisms [reviewed
in Ref. (27) and (28)]. The global architecture of injectisomes is
conserved between bacteria and comprises a needle complex, com-
posed of two pairs of rings that are connected by a rod, spanning
the inner and outer bacterial membranes. This structure has at its
end a hollow needle, a filament, or a pilus. The main function of
T3SSs is to deliver effector proteins across the membranes of host
cells, in which these molecules are able to activate cell signaling
pathways.
Similarly, T4SSs are specialized macromolecular machines that
can deliver DNA and/or proteins to host cells. In contrast to T3SSs,
however, those of the type-4 family are believed to be related
to bacterial conjugation systems, rather than the flagellar appa-
ratus. T4SSs have been identified in many Gram-negative and
-positive bacteria, as the complex can span both types of mem-
brane [reviewed in Ref. (28) and (29)]. T4SSs are classified as
Type A or B, depending on structure composition, but both aim
to deliver bacterial effectors to host cells. The Type A T4SSs are
defined by their homology with the VirB/D4 system of the plant
pathogen Agrobacterium tumefaciens, whereas the Type B T4SSs
are closer to the conjugal transfer systems of the self-transmissible
IncI plasmid (29).
The first study to report a mechanism for the recognition of
extracellular bacteria by intracellular receptors was described by
Viala et al. who showed how virulent Helicobacter pylori strains
are able to activate the cytosolic NLR family member, nucleotide-
binding oligomerization domain-containing protein 1 (NOD1)
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FIGURE 1 | Mechanisms used by bacteria to activate NLR signaling in
host cells. A schematic overview of the major NLR signaling pathways
activated during bacterial infection, showing the mechanisms whereby
extracellular MAMPs are sensed by intracellular NLRs. Upon detection of the
appropriate signal, NLRs are believed to oligomerize and recruit adaptor
proteins to transduce the signal to downstream effector proteins.
(6). Specifically, the authors showed that H. pylori strains with
a functional T4SS were able to deliver degradation products of
Gram-negative cell wall peptidoglycan, identified as potent acti-
vators of NOD1 signaling (30), to epithelial cells (Table 1). The
mechanism of how H. pylori peptidoglycan is delivered to cytoso-
lic NOD1, however, is still unclear, even if it was reported that
depletion of cholesterol-rich domains, or lipid rafts, interferes with
peptidoglycan delivery into host cells (31). In any case, H. pylori
T4SS-dependent induction of the NOD1 pathway was shown to
result in the downstream activation of NF-κB and MAP kinases,
most likely through the recruitment of the serine-threonine kinase
adaptor molecule, RIP2 (32, 33). These findings are consistent
with the general view that the NOD1 signaling pathway con-
verges on the master transcriptional regulator, NF-κB, leading to
pro-inflammatory cytokine production [reviewed in Ref. (34)].
One group, however, suggested that NOD1 signaling is largely
independent of NF-κB and MAPK activation (35). Instead, these
workers presented data showing that the dominant response medi-
ated by NOD1 activation involves the formation of a complex
known as IFN-stimulated gene factor 3 (ISGF3) and production
of CXCL10 and type I IFN by epithelial cells (35). The authors
demonstrated that stimulation of AGS gastric epithelial cells with
either a synthetic NOD1 agonist or live H. pylori bacteria alone
induced increased CXCL10 production. Nevertheless, the poten-
tial link between NOD1 and type I IFN in epithelial cell responses,
though interesting, awaits confirmation by other researchers.
Since the work on the role of NOD1 in H. pylori sensing, other
bacterial pathogens have been identified as also being activators
of this pathway, e.g., Pseudomonas aeruginosa and Campylobac-
ter jejuni (36, 37). These bacteria have essentially extracellular
lifestyles, although some data suggest that NOD1 activation in
these infection models may be due to the presence of intracellular
bacteria. However, even if invasive P. aeruginosa and C. jejuni have
been shown to be present in defined intracellular structures, pep-
tidoglycan delivery, and activation of cytoplasmic sensors, such as
NOD1,must still require an efficient secretion system (38,39). Fur-
thermore, a recent study has shown that Salmonella typhimurium
activation of NOD1 and NOD2, a related molecule that senses all
forms of bacterial peptidoglycan, may be invasion-independent
but requires an intact T3SS for the injection into the cytoplasm
of the bacterial protein, SipA (10). This work, identifying a novel
agonist of NOD1- and NOD2-signaling, suggests that these NLR
family members may be activated through a distinct pathway from
that induced by bacterial peptidoglycan. The same group suggested
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recently that NOD1 could sense other patterns of pathogenesis,
such as modification of the actin cytoskeleton. According to this
intriguing new model, a T3SS-secreted protein of S. typhimurium,
SopE, activates the small Rho GTPases, which then triggers the
NOD1 signaling pathway (40).
Another major NLR family member that is activated by extra-
cellular pathogens through the action of bacterial secretion sys-
tems is the CARD-containing protein, NLRC4 (previously known
as Ice Protease-Activating Factor, IPAF) (Table 1). The early para-
digm for NLRC4 activation was that this NLR senses bacterial fla-
gellin within the cytoplasmic compartment of cells. Specifically, it
was shown that T3SS-dependent translocation of S. typhimurium
and P. aeruginosa flagellin into the host cell triggered NLRC4 acti-
vation in macrophages (41–44). Interestingly, subsequent reports
contradicted this hypothesis as both Shigella flexneri, an aflagel-
lated bacterium,and P. aeruginosa were also able to activate NLRC4
inflammasome in a flagellin-independent, but T3SS-dependent
mechanism, suggesting the existence of one or several other lig-
ands (45, 46). These findings have since been confirmed in various
bacterial species and the molecules responsible for NLRC4 activa-
tion have now been identified. Thus, it was shown that the basal
body rod components of T3SSs (rod protein) are detected during
infection with either S. typhimurium (PrgJ), Burkholderia pseudo-
mallei (BsaK),Escherichia coli (EprJ and EscI),S. flexneri (MxiI),or
P. aeruginosa (PscI) (47). Interestingly, all these proteins appear to
share a sequence motif present in the carboxy terminal region that
is conserved in the flagellar protein, FliC, and detected by NLRC4
(47). The mechanism of how NLRC4 is able to sense and respond
to two distinct bacterial products, flagellin or PrgJ-like proteins,
has thus been deciphered. Concomitant animal infection studies
from two different groups showed that the specificity of the NLRC4
inflammasome is determined by different NAIP paralogs (11, 12).
In these new models, both flagellin and rod protein are injected
through the T3SS and are specifically recognized by NAIP5/6 or
NAIP2 respectively, confirming previous studies showing a physi-
cal association between NLRC4 and NAIP5 (Figure 1) (11, 12, 48).
Interestingly, humans possess only one Naip gene compared with
the six Naip genomic loci in mice, and the specificity of human
NAIP appears to be different to the murine NAIPs as it is unrespon-
sive to intracellular delivery of flagellin or PrgJ-like rod proteins
(12). Although it has been shown that a PrgJ homolog, from the
bacterium Chromobacterium violaceum, is specifically recognized
by human NAIP (12), further studies are required to determine
the importance of human NAIP during infection with common
bacterial pathogens.
T4SS and flagellin have also both been suggested to play
roles in NLRC4 activation during Legionella replication within
macrophages, since the presence of all three elements (i.e., flagellin,
a functional T4SS and NLRC4) is required to activate caspase-
1 in these cells. Consistent with these findings, in vivo studies
confirmed that clearance of Legionella pneumophila required the
presence of both flagellin and NLRC4 (49).
Finally, bacterial secretion systems have recently been impli-
cated in the activation of the NLR PYD-containing protein 12
(NLRP12) by the pathogen, Yersinia pestis (Table 1) (13). The
nature of the NLRP12 ligand is still unknown, however, by using a
Y. pestis strain which lacks the virulence plasmid necessary for the
formation of a T3SS, the authors were able to show that this secre-
tion system was required for inflammasome activation and IL-1β
release in bone marrow-derived macrophages (BMDMs) (13). The
precise mechanism by which the Y. pestis T3SS mediates NLRP12
inflammasome activation remains to be elucidated.
OUTER MEMBRANE VESICLES
In addition to bacterial secretion systems, in which individual
proteins or macromolecules are secreted, bacteria have devel-
oped other mechanisms to transfer a wide variety of components
within the host cells. The release of outer membrane vesicles
(OMVs) is one such strategy developed by Gram-negative bacte-
ria to secrete toxins, enzymes, DNA, adhesins, or other periplasmic
constituents into the extracellular medium [reviewed in Ref. (50)].
It is also noteworthy that the commensal bacterium, Bacteroides
fragilis, releases a capsular polysaccharide in its OMVs that has
immunomodulatory effects and can prevent inflammation in an
experimental colitis model (51). OMVs are released by virtu-
ally all Gram-negative bacteria, whereas the level of expression
differs between bacterial species (50). More recent reports also
suggest that Gram-positive bacteria can secrete membrane vesicles,
however, these are less well studied than those of Gram-negative
organisms (52, 53). OMVs can be released under different con-
ditions in vitro and in vivo from free-living cells, biofilms, or by
internalized bacteria (54–56).
The primary roles of OMVs are believed to be the delivery
of toxins or bacterial components into host cells and the eva-
sion of host immune responses (57). On the other hand, several
studies have revealed that OMVs are able to induce inflammatory
responses that may protect the host from infection. Indeed, OMVs
contain different MAMPs, including LPS, flagellin, or DNA that
could be recognized by TLR and NLR family members (51, 58,
59). Traditionally, many studies in the literature have focused on
OMV-associated LPS, however, it is now becoming apparent that
peptidoglycan represents a major promoter of the inflammatory
responses induced by OMVs. An initial clue to the potential role of
OMV-associated peptidoglycan in innate immunity arose from the
observation that S. flexneri culture supernatants, when microin-
jected into epithelial cells, induced the activation of the NF-κB
signaling pathway (30, 60). Indeed, it was shown that the OMVs
normally present in such supernatants are able to enter non-
phagocytic cells and deliver peptidoglycan directly to cytoplasmic
NOD1, resulting in the up-regulation of NF-κB and IL-8 responses
in cells (Figure 1) (7). This OMV-dependent mechanism of NOD1
activation was demonstrated for three extracellular pathogens:
H. pylori, P. aeruginosa, and Neisseria gonorrhoeae (Table 1) (7).
Moreover, it was shown that Nod1-deficient mice intragastrically
fed with H. pylori OMVs failed to mount local Cxcl2 and sys-
temic antibody responses, when compared with their wild-type
littermates (7).
Subsequent studies reported that Vibrio cholerae strains, which
also produce large amounts of OMVs, can promote immune
responses in the host via a NOD1- and NOD2-dependent mech-
anism (8, 9). OMVs isolated from Moraxella catarrhalis have also
been shown to induce IL-8 production through TLR2-initiated
NF-κB activation, but a role for NOD1 could not been excluded,
as cellular responses to whole bacteria involved both TLR2 and
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NOD1 (61, 62). Pro-inflammatory responses to OMVs were
also observed for several other bacteria [reviewed in Ref. (50)],
however, the role of peptidoglycan in these responses was not
assessed.
Besides peptidoglycan, OMVs contain other molecules able to
activate the innate immune system. For example, N. gonorrhoeae
OMVs contain lipooligosaccharide (LOS) which has been shown
to activate NLRP3-induced IL-1β secretion and pyronecrosis in
monocytes and macrophages (Figure 1) (14, 15). This LOS-
mediated activation of the NLRP3 inflammasome is believed to
be triggered by the release of cathepsin B (15).
Mechanistic data on OMV uptake are scarce, but recent find-
ings suggest that disruption of lipid rafts by treatment with
Fumonisin B1, an inhibitor of sphingomyelin incorporation into
lipid rafts, or methyl-β-cyclodextrin, a cholesterol-depleting agent,
abrogates both internalization and NOD1-dependent immunos-
timulatory capacity of OMVs (7). The mechanism and intracellu-
lar compartment(s) involved in NOD1 sensing of OMV-associated
peptidoglycan, however, have yet to be determined.
The findings concerning the role of peptidoglycan delivery by
OMVs provide a new mechanism to understand how extracellular
bacteria, which are unable to invade cells or to inject components
through a secretion system, may be able to initiate innate immune
signaling in non-phagocytic cells, such as epithelial cells.
PORE-FORMING TOXINS
In addition to OMVs, bacteria may secrete toxins to alter host cell
integrity distant to the original point of invasion. Among these
proteins are the pore-forming toxins (PFTs), which are produced
by a wide range of pathogens. PFTs are secreted in a soluble form
and are subsequently multimerized into a transmembrane channel
that perforates the plasma membrane of host cells. Pore formation
may be an entry door for bacterial molecules to penetrate into
host cells or lead to cellular ion imbalance (63). Efforts during
the last decade have been focused on determining how cells are
able to mount a response against pore formation, thereby con-
trasting with the existing paradigm, which suggested that cells
possessed no defenses against these toxins and that the only out-
come was cell death (63, 64). Numerous studies, indeed, found
that stimulation of immune cells with different PFTs activates
pro-inflammatory signaling or vacuolation in response to treat-
ment [(65); and reviewed in Ref. (64)]. It is also noteworthy that
the concentrations of PFTs during in vivo infection could be sub-
lytic, thus allowing cells to mount an antibacterial response (66),
capable of controlling the infection.
Recent intensive studies on PFTs and cellular responses have
revealed a major role for NLRP3 in the sensing of pore formation.
Mariathasan et al. demonstrated a role for listeriolysin O from
Listeria monocytogenes, as well as for an unknown Staphylococcus
aureus toxin, in inflammasome activation and IL-1β production
(Table 1). Furthermore, this study speculated that the observed
effects were dependent on intracellular potassium levels (Figure 1)
(17). Concerning S. aureus, recent studies showed that caspase-1
activation requires the presence of all three of its α-, β-, and γ-
hemolysins and the release of bacterial lipoproteins (19, 24). In
addition, a small percentage of S. aureus isolates also produce
another toxin, named Panton–Valentine leukocidin (PVL), which
is able to trigger NLRP3 inflammasome activation (25). These
results were confirmed using aerolysin from Aeromonas hydrophila
which was shown to mediate the efflux of intracellular potas-
sium ions and activation of caspase-1 through the assembly of
NLRC4 and NLRP3 inflammasomes (16). Subsequent studies sug-
gested that aerolysin from either A. veronii or A. hydrophila acti-
vates only the NLRP3 inflammasome, through potassium efflux,
whereas NLRC4 activation was T3SS-dependent but potassium-
independent (21, 22). During the last decade, a large number of
bacterial PFTs have been shown to be able to activate NLRP3
via the same molecular mechanism of potassium efflux. These
PFTs include the adenylate cyclase toxin (CyaA) from Bordetella
pertussis (20), pneumolysin from Streptococcus pneumoniae (23),
HlyA hemolysin and MARTX from Vibrio vulnificus and V. cholerae
(23), streptolysin O from Streptococcus pyogenes (18). Even if the
molecular mechanism is unclear, NLRP3 inflammasome assem-
bly occurs spontaneously at low potassium concentrations and is
prevented at higher concentrations, thus confirming its role in the
detection of DAMPs (67). In a recent study, potassium efflux was
shown to be the minimal membrane permeabilization event trig-
gering NLRP3 inflammasome activation by PFTs and particulate
matter (68).
In contrast to our understanding of NLRP3 biology, far less
is known about activation of the NLRP1 inflammasome and its
activation by PFTs. The human Nlrp1 gene has three murine par-
alogs,which encode proteins lacking the N-terminal PYD sequence
found in human NLRP1 (69). Sensitivity of mice to the effects of
anthrax lethal toxin from Bacillus anthracis has been correlated
with a polymorphism in the Nalp1b gene, encoding Nlrp1 (26).
Due to the absence of a PYD domain in the mouse sequence of
Nlrp1, it is not clear whether caspase-1 recruitment requires ASC
or dimerization with another NLRP. However, recent data suggest
that upon stimulation with anthrax lethal toxin, NLRP1 under-
goes autoproteolysis to form an inflammasome (70). Interestingly,
inflammasome formation and caspase-1 recruitment are inhib-
ited by high levels of potassium (71). Hsu et al. demonstrated a
role for NOD2 in lethal toxin-induced IL-1β production and sug-
gested the formation of a complex between NLRP1 and NOD2
(72). This association has since been confirmed by other authors
(73). Interestingly, NOD2-recognition of S. aureus is facilitated by
the presence of its hemolysin, probably by promoting cytoplasmic
access of NOD2 ligand (74).
Synergistic responses from the activation of multiple NLR path-
ways have been observed following co-stimulation with two differ-
ent pathogens. Indeed, it was shown that Haemophilus influenzae
peptidoglycan enters epithelial cells more efficiently in the pres-
ence of S. pneumoniae pneumolysin, suggesting the ability of intra-
cellular NLRs to sense extracellular bacteria that do not encode
secretion systems or express OMVs or PFTs (75). One hypothesis
from the authors is that host organisms have evolved to detect a
combination of pathogens in order to mount optimal responses
in ways that are different to the responses induced by a single
infection. It is now recognized that co-infection plays a previously
unappreciated yet important role in the development of mucosal
immunity and disease progression (76).
In conclusion, increasing numbers of studies suggest that
osmotic changes induced by pore formation may be sensed by
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intracellular NLRs as an early warning system (68). Furthermore,
these signals can cooperate with other signaling pathways, thus
leading to the generation of antibacterial responses before the
concentration of PFTs reaches a lytic concentration.
ENDOCYTOSIS
Asides from the active processes described above, intracellular
NLRs may be activated by passive mechanisms. One such mech-
anism involves cellular entry by the peptidoglycan fragments that
are released during bacterial growth or are degraded by host
enzymes. Bacteria express peptidoglycan-degrading enzymes, nec-
essary for maintaining functional growth, division, and develop-
ment [reviewed in Ref. (77, 78) and (79)]. In addition to their role
in shaping bacterial membranes, these enzymes are responsible
for the release of free peptidoglycan fragments in the extracellu-
lar compartment. It is thus possible that these fragments interact
with surrounding organisms, mediating pathogenic effects on host
cells, as mutations in peptidoglycan-recycling proteins result in
decreased pathogenesis. Conversely, released peptidoglycan frag-
ments can also play a role in symbiotic relationships, such as is the
case with Vibrio fischeri, which induces developmental changes in
its squid host [reviewed in Ref. (77)]. Moreover, peptidoglycan
can have effects on host cells distant to the point of its release.
For example, peptidoglycan released in the gut was shown to cir-
culate and play a major role in the priming of neutrophils in
the bone marrow (80). Interestingly, a study by Hasegawa et al.
characterizing NOD1- and NOD2-stimulatory activities in dif-
ferent bacterial preparations, showed that the highest levels of
NOD1-stimulatory activity were found predominantly in culture
supernatants, whereas NOD2 activity was associated with extracts
from whole bacterial cells (81). This study further underscores the
likely important role of released peptidoglycan during infection
with extracellular bacteria.
On the other hand, host cells have also developed some mecha-
nisms to degrade bacterial peptidoglycan in order to kill invading
pathogens and provide ligands to host receptors [reviewed in Ref.
(82)]. Enzymes such as lysozyme or peptidoglycan recognition
protein family members generate fragments small enough to be
sensed by NOD1 and NOD2 (82, 83).
In the context of extracellular pathogens, we can then wonder
how these peptidoglycan fragments are processed to be presented
to intracellular innate immune sensors. It is now established that
different internalization mechanisms can be used by the host
cell and these are probably cell-type dependent. In the case of
epithelial cells, it has been reported that NOD1 and NOD2 lig-
ands are likely to be internalized by clathrin-mediated endocytosis
(84, 85). In immune cells, it is more likely that internalization
occurs through phagocytosis. Interestingly, it has been observed
that Nod1- or Nod2-deficient mice have decreased phagocytic
abilities (86, 87).
Once the fragments have been internalized in vesicles by
clathrin-mediated endocytosis or phagocytosis, they have to be
delivered across membranes and be presented to the cytosolic
molecules, NOD1 and NOD2. This mechanism implies the pres-
ence of specific transporters, with the transporter family SLC15
having been proposed to play a role. This transporter family
comprises membrane proteins controlling the cellular uptake of
di/tripeptides and peptide-like drugs [reviewed in Ref. (88)]. Roles
for SLC15A4 (PHT1) and SLC15A2 (PepT2) have indeed been
identified for the delivery of NOD1-ligands (Figure 1) (84, 89,
90). Another member of this family, SLC15A1 (PepT1), is believed
to play a role in NOD2 ligand transport (85, 91). Nevertheless,
the specificity of each of these transporters is still unclear, as
both the minimal motif recognized by NOD1, iE-DAP (γ-d-Glu-
mDAP), and the NOD2 agonist, MDP (MurNAc-l-Ala-d-isoGln,
also known as muramyl dipeptide) may be delivered through
SLC15A2 (89, 92). Interestingly, there are higher expression lev-
els of SLC15A1, SLC15A2, and SLC15A4 in the small intestine,
with lower bacterial loads of 103 organisms per gram, than in the
colon, where microbial densities reach 1012 organisms per gram.
This may suggest a role for such transporter proteins in MAMP
uptake [reviewed in Ref. (93), and (1)].
CONTROL OF ADAPTIVE IMMUNITY
Activation of NLRs has been shown to prime T and B cells, sug-
gesting the contribution of these innate immune molecules in the
development of adaptive immune responses. Interestingly, many
of the known NLRs activators (e.g., MDP, flagellin, alum) play
roles as adjuvants during vaccination, suggesting a role for these
molecules in tailoring the adaptive immune response [reviewed in
Ref. (94)].
The most striking example is the role played by NOD2 in the
mediation of the adjuvant effect of complete Freund’s adjuvant,
first described in 1937 (95). The adjuvant activity of this com-
pound, which is composed of paraffin oil and Mycobacterium
tuberculosis extract, is believed to be attributed to its ability to
prolong antigen release, to promote the recruitment of immune
cells and antigen presentation by inducing expression of cytokines
and chemokines [reviewed in Ref. (96)]. The minimal component
of complete Freund’s adjuvant was subsequently identified to be
MDP, as this molecule provided the same level of adjuvant activity
as whole killed M. tuberculosis (97). The mechanism responsible
for the activity of Freund’s adjuvant was determined less than
10 years ago by Kobayashi et al. who showed that NOD2 was
required for the development of protective immunity mediated
by the adjuvant effects of MDP (98). During immunization assays
in Nod2−/− animals, a severe deficiency was observed in the pro-
duction of antigen-specific immunoglobulins, specifically in those
of the IgG1 subclass, suggesting that NOD2 is able to activate the
adaptive immune system and promote the production of antibod-
ies to T cell-dependent antigens (98). These results were confirmed
subsequently, when it was shown that MDP injection in mice
triggered Th2 polarized responses in a NOD2-dependent manner
(99). Specifically, it was shown that Nod2-deficient mice displayed
impaired chemokine and Th2 responses with low numbers of
splenic IL-4- and IL-5-producing T cells, as well as the loss of
antigen-specific T and B cell responses (99). Interestingly, NOD2
can also cooperate with TLRs to generate Th1-polarized responses
to co-stimulation with MDP and TLR2 or TLR4 ligands, suggesting
the importance of complementary effects between TLRs and NLRs
in the balance of immune effector responses (99). In addition to
the recognition of MDP by NOD2, dual recognition of a mycobac-
terial glycolipid, also known as cord factor, and peptidoglycan is
essential for Th17-differentiation in an inflammasome-dependent
Frontiers in Immunology | Molecular Innate Immunity October 2013 | Volume 4 | Article 344 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ferrand and Ferrero NLR sensing of extracellular bacteria
manner (100). It was shown that recognition of both the mycobac-
terial cord factor by the CARD9-dependent C-type lectin receptor
mincle and peptidoglycan, via a NOD1- and NOD2-independent
mechanism, induces inflammasome activation and IL-1β secretion
and thus drives skewed Th17 responses.
NOD1 stimulation has also been shown to be sufficient to drive
antigen-specific immunity with a predominant Th2 polarization
profile and to play a role in the onset of Th1, Th2, and Th17
immune pathways in conjunction with TLR stimulation (101).
Thus, depending on the presence of different MAMPS and the co-
stimulation of TLRs, NOD receptors can initiate different arms of
the adaptive response. Although data are still scarce concerning the
role of NOD1 and NOD2 in the onset of adaptive immunity dur-
ing microbial infection, H. pylori-infected Nod1-deficient mice
exhibited reduced Th1 immune responses compared with their
WT littermates (101). Similar results were obtained in M. tubercu-
losis or S. pneumoniae-infected Nod2-deficient mice, with lower
titers of pathogen-specific serum IgG and diminished antigen-
specific T cell responses (102, 103). Consistent with these data,
Citrobacter and Salmonella infections triggered Th17 responses
that were dependent on NOD1 and NOD2 (104).
Injection of bone marrow reconstituted mice with NOD1 or
NOD2 agonists and ovalbumin allowed the group of Philpott
and collaborators to determine the importance of stromal fac-
tors, versus hematopoietic cells, in the initiation of Th2 immune
responses (101, 105). In addition, that group showed that the
capacity of NOD1 ligand to cooperate with TLR agonists was com-
pletely abolished in Nod1-deficient bone marrow-derived den-
dritic cells (BMDCs) (101). Similarly, Nod2-deficiency in BMDCs
abolished pro-inflammatory cytokine production upon stimula-
tion with MDP alone, whereas synergy between MDP and TLR
ligands was lost in Nod2-deficient BMDMs (98). Additionally,
full responses required sensing within the hematopoietic com-
partment, with a major role for dendritic cells, consistent with
the well-established role of dendritic cells in the onset of adaptive
immunity (105, 106). Furthermore, co-stimulation with NOD1
or NOD2 agonists in combination with TLR agonist induced a
synergistic production of Th1-associated cytokines IFN-γ and
IL-12 (107).
In contrast to the now well-defined role of NOD proteins in tai-
loring adaptive immune responses, the role of the NOD1/2 adaptor
protein, RIP2, is less well-defined. Several early works in in vivo
or in vitro RIP2-deficient models demonstrated impairment in
the development of anti-infectious responses, NF-κB signaling,
or T cell proliferation and differentiation (108–110). On the other
hand, more recent papers, all of them using the same mouse model
but different to those used previously, claimed an absence of effect
of RIP2 in T cell proliferation and T helper differentiation (111,
112). A comparison of the different RIP2-knockout mouse lines
may help to resolve these differences.
Recent studies have shown that non-hematopoietic cells can
also be of importance during the development of adaptive immune
responses. Indeed, Watanabe et al. proposed that activation of
NOD1 and NOD2 in gastrointestinal epithelial cell lines induces
production of cytokines associated with a Th1 response (35). They
also proposed that NOD1 signaling, through ISGF3 activation
and type I IFN responses, may lead to Th1 differentiation and
Th1-dependent inflammation (35).
Concerning the other NLR family members, further studies
will be needed to help to understand their roles in adaptive immu-
nity. It has been shown using the Listeria infection mouse model
that strains that activated the inflammasome generated signifi-
cantly less protective immunity, a phenotype that correlated with
decreased induction of antigen-specific T cells (113). It is note-
worthy that IL-1 family cytokines, including IL-1β and IL-18, have
adjuvant properties, as they can induce antigen-specific immune
responses against infection (114). For example, CyaA, a pore-
forming toxin from B. pertussis, activates the NLRP3 inflamma-
some and induces IL-1β expression, thereby playing a critical role
in promoting antigen-specific Th17 cells and in generating pro-
tective immunity against B. pertussis infection (20). Interestingly,
a recent report suggested that IL-1β production in trophoblasts
after Chlamydia trachomatis infection may also be mediated by
NOD1, but the signaling pathway involved remains unclear (115).
In addition, IL-1β may be secreted after non-canonical inflam-
masome activation, where an intracellular lipid A moiety of LPS
has been showed to play major roles in the induction of TLR4-
independent inflammatory responses (116). Although the receptor
has as yet to be characterized, these results suggest a new mecha-
nism of intracellular sensing in the mounting of innate immune
responses against microbial infection.
CONCLUDING REMARKS
As discussed above, various NLR family members have evolved to
detect infection and mount effective immune responses mediated
by both innate and adaptive arms of the immune system. Asides
from these NLR family members, it is possible that other fam-
ily members could play roles during infection with extracellular
bacteria. Indeed, NLRP6-deficiency in mice was shown to result
in increased inflammation, to alter the colonic microbial ecology
and was associated with susceptibility to colorectal tumorigene-
sis (117, 118). More recently, NLRP6 has been shown to inhibit
NF-κB translocation and MAPK activation, with NLRP6 activa-
tion leading to increased susceptibility to both intracellular and
extracellular bacteria (119). Thus, a second subclass of NLR family
members, such as NLRP6 or NLRC5,may act as molecular switches
to dampen host responses induced by extracellular bacteria. For
example, NLRC5 has been suggested to interact with NF-κB reg-
ulators, IKKα and IKKβ, and to block their phosphorylation so as
to modulate inflammatory signaling to bacterial pathogens (120).
Discordant results were, however, obtained in different studies
(121–123), suggesting that further investigations are required to
fully elucidate the role(s) of NLRC5 in host responses to micro-
bial pathogens. Besides the NLR family members described in this
review, other intracellular molecules, such as certain TLRs (i.e.,
TLR3, TLR9) or Absent In Melanoma 2 (AIM2), are able to detect
nucleic acids from extracellular bacteria, allowing a wide range of
MAMPs to be sensed.
The different examples of infection sensing described above
highlight the existence of dual systems of recognition for MAMPs
from extracellular bacteria. First, conserved molecular patterns
in bacteria may be recognized by extracellular receptors. For
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instance, sensing of bacterial lipoproteins by TLR2, LPS by TLR4
or flagellin by TLR5 have been relatively well described. Acti-
vation of these extracellular receptors leads to a transcriptional
inflammatory response with production of type I IFNs or pro-
inflammatory cytokines, such as TNF-α or IL-12. However, par-
ticular cytokines, including IL-1β or IL-18, require an additional
post-transcriptional step to be fully functional. A growing amount
of evidence suggests that the signaling involved in this post-
transcriptional response is due to activation of inflammasome
complexes, after sensing of microbes or danger signals by intracel-
lular molecules, including the NLRs. However, some intracellular
sensors of extracellular bacteria, such as NOD1 and NOD2, do
not induce inflammasome formation and are generally thought
to activate NF-κB signaling instead. Nevertheless, we can reason-
ably hypothesize that host cells are able to distinguish between the
signals originating from extracellular and intracellular pathogens,
through the intensity, kinetics, or cell-specific nature of the signal.
This dual recognition of the pathogen itself, or of the con-
sequences of the infection, may be of importance to finely tune
inflammatory responses in line with the threat. One hypothesis is
that non-pathogenic bacteria may be recognized by extracellular
receptors only, whereas pathogenic extracellular or invasive bac-
teria will be sensed by both families of receptors, leading to more
intense responses, suggesting that synergy between TLRs and NLRs
may be required for optimal responses. As evoked in this review,
it was found that NLR family members may synergize with TLR-
dependent cytokine expression (124). An interesting example of
this possible dual recognition would be the gut, where there is
exposure to more than 500 species of commensal microorgan-
isms. It has been shown that TLR agonists induced tolerance to
subsequent stimulation with the same agonist (125). This process
could thus play a role in the induction of tolerance to commen-
sal bacteria, whereas pathogenic microorganisms could then be
sensed by NLR family members.
It is possible that, depending on the cell type, host cells may dis-
tinguish between the signal originating from TLRs and NLRs. Gut
immunology provides a good example of how this might work.
Indeed, the intestinal epithelium is composed of different layers
allowing discrimination between commensal and pathogenic bac-
teria. The outermost of these layers, comprising the mucus, is a
barrier surrounding intestinal epithelial cells. Some areas of the
intestinal epithelium, such as the Peyer’s patches, are devoid of
mucus and serve as inductive sites for the mucosal immune sys-
tem. In addition, dendritic cells can extend pseudopodes through
the mucus and reach the lumen [reviewed in Ref. (126)]. This
multi-layer system could allow the host to distinguish between a
commensal, which should not progress through the mucosa, and
a pathogen, which could disseminate beyond this layer and/or
present bacterial components to the epithelium (127). Hence,
the ability of the host to distinguish between commensals and
pathogens and to mount efficient immune responses could be
dependent on how and where the MAMPs are sensed (128).
As discussed in this review, activation of NLR-dependent sig-
naling pathways by extracellular bacteria induces the direct pro-
duction of pro-inflammatory molecules and also tailors and drives
adaptive immunity, suggesting that NLR family members are mul-
tifaceted proteins. A comprehensive understanding of the func-
tions of NLRs will help decipher their roles in shaping both
innate and adaptive immunity during infection with extracellular
pathogens.
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